Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2005 Apr;81(2):147–149. doi: 10.1136/sti.2004.010868

The response to sertraline in men with chronic pelvic pain syndrome

R Lee 1, R West 1, J Wilson 1
PMCID: PMC1764675  PMID: 15800093

Abstract

Objectives: Male chronic pelvic pain syndrome (CPPS) is difficult to manage. Although antidepressants are frequently used in clinical practice, to date no interventional study has been published. We investigated men with CPPS to assess their response to the serotonin specific reuptake inhibitor (SSRI) antidepressant, sertraline.

Methods: Men with CPPS underwent a four glass test to exclude an infective cause for their symptoms. They were randomised to sertraline or matched placebo for 13 weeks after which they were unblinded. They were then allowed to either continue sertraline or cross over to active treatment for a further 13 weeks. Prostatic symptom severity (PSS) and frequency (PSF) scores, the Hospital Anxiety and Depression (HAD) scale and a psychosexual (PSex) questionnaire were completed at 0, 6, 13, and 26 weeks. Statistical analysis was by the Mann-Whitney U and Wilcoxon signed rank tests.

Results: 14 men enrolled. At week 13 there was a mean reduction in PSS scores of 6.1 in the active and 2.0 in placebo group, and in PSF scores of 3.6 and 1.0, respectively. There was no statistically significant difference in the PSS and PSF scores between the active versus placebo group because of the small subject numbers. If analysed as a case series, there was a significant reduction in PSS (11.7; p = 0.01) and PSF (5.9; p = 0.03) from baseline following 13 weeks of sertraline. There was also a decrease in mean HAD depression score from 4.6 at baseline to 2.4.

Conclusion: Sertraline led to a significant improvement in prostatic symptom severity and frequency from baseline following 13 weeks of treatment. Although this analysis does not exclude a placebo effect, the randomised placebo controlled findings show a trend to improvement with sertraline when compared to placebo.

Full Text

The Full Text of this article is available as a PDF (53.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbalias G. A., Meares E. M., Jr, Sant G. R. Prostatodynia: clinical and urodynamic characteristics. J Urol. 1983 Sep;130(3):514–517. doi: 10.1016/s0022-5347(17)51281-1. [DOI] [PubMed] [Google Scholar]
  2. Barbalias G. A. Prostatodynia or painful male urethral syndrome? Urology. 1990 Aug;36(2):146–153. doi: 10.1016/0090-4295(90)80214-8. [DOI] [PubMed] [Google Scholar]
  3. Barry M. J., Fowler F. J., Jr, O'Leary M. P., Bruskewitz R. C., Holtgrewe H. L., Mebust W. K., Cockett A. T. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992 Nov;148(5):1549–1564. doi: 10.1016/s0022-5347(17)36966-5. [DOI] [PubMed] [Google Scholar]
  4. Berghuis J. P., Heiman J. R., Rothman I., Berger R. E. Psychological and physical factors involved in chronic idiopathic prostatitis. J Psychosom Res. 1996 Oct;41(4):313–325. doi: 10.1016/s0022-3999(96)00157-2. [DOI] [PubMed] [Google Scholar]
  5. Egan K. J., Krieger J. N. Psychological problems in chronic prostatitis patients with pain. Clin J Pain. 1994 Sep;10(3):218–226. doi: 10.1097/00002508-199409000-00008. [DOI] [PubMed] [Google Scholar]
  6. Jung A. C., Staiger T., Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med. 1997 Jun;12(6):384–389. doi: 10.1046/j.1525-1497.1997.00064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Krieger J. N., Egan K. J., Ross S. O., Jacobs R., Berger R. E. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology. 1996 Nov;48(5):715–722. doi: 10.1016/S0090-4295(96)00421-9. [DOI] [PubMed] [Google Scholar]
  8. Litwin M. S., McNaughton-Collins M., Fowler F. J., Jr, Nickel J. C., Calhoun E. A., Pontari M. A., Alexander R. B., Farrar J. T., O'Leary M. P. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999 Aug;162(2):369–375. doi: 10.1016/s0022-5347(05)68562-x. [DOI] [PubMed] [Google Scholar]
  9. Luzzi G. A., Bignell C., Mandal D., Maw R. D., British Co-operative Clinical Group Chronic prostatitis/chronic pelvic pain syndrome: national survey of genitourinary medicine clinics. Int J STD AIDS. 2002 Jun;13(6):416–419. doi: 10.1258/095646202760029859. [DOI] [PubMed] [Google Scholar]
  10. McKay M. Dysesthetic ("essential") vulvodynia. Treatment with amitriptyline. J Reprod Med. 1993 Jan;38(1):9–13. [PubMed] [Google Scholar]
  11. Meares E. M., Stamey T. A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968 Mar;5(5):492–518. [PubMed] [Google Scholar]
  12. Miller J. L., Rothman I., Bavendam T. G., Berger R. E. Prostatodynia and interstitial cystitis: one and the same? Urology. 1995 Apr;45(4):587–590. doi: 10.1016/S0090-4295(99)80048-X. [DOI] [PubMed] [Google Scholar]
  13. Nickel J. C., Sorensen R. Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. J Urol. 1996 Jun;155(6):1950–1955. doi: 10.1016/s0022-5347(01)66056-7. [DOI] [PubMed] [Google Scholar]
  14. Segura J. W., Opitz J. L., Greene L. F. Prostatosis, prostatitis or pelvic floor tension myalgia? J Urol. 1979 Aug;122(2):168–169. doi: 10.1016/s0022-5347(17)56309-0. [DOI] [PubMed] [Google Scholar]
  15. Terasaki T., Watanabe H., Saitoh M., Uchida M., Okamura S., Shimizu K. Magnetic resonance angiography in prostatodynia. Eur Urol. 1995;27(4):280–285. doi: 10.1159/000475181. [DOI] [PubMed] [Google Scholar]
  16. Wenninger K., Heiman J. R., Rothman I., Berghuis J. P., Berger R. E. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol. 1996 Mar;155(3):965–968. [PubMed] [Google Scholar]
  17. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  18. de la Rosette J. J., Ruijgrok M. C., Jeuken J. M., Karthaus H. F., Debruyne F. M. Personality variables involved in chronic prostatitis. Urology. 1993 Dec;42(6):654–662. doi: 10.1016/0090-4295(93)90529-j. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES